← Back to Search

Self-adaptive serious game for Aging (SAVinGs Trial)

N/A
Recruiting
Led By Charles Sebiyo Batcho, PT, PhD
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Normal-to-corrected vision
Age > or = 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (before intervention), day 2 and day 3 (at the end of the intervention)
Awards & highlights

SAVinGs Trial Summary

This trial aims to investigate the impact of self-adaptive serious games, compared to traditional serious games, on motor skill learning and attention in older adults. The study will also explore how motor skill learning in

Who is the study for?
This trial is for older adults aged 65 or above with normal-to-corrected vision and a Montreal Cognitive Assessment score over 24, indicating they have no significant cognitive impairment. It's designed to help those who are generally healthy but may be experiencing the effects of aging on motor skills and attention.Check my eligibility
What is being tested?
The study compares two types of serious games: one that self-adapts to the player's ability (self-adaptive) and another that does not change difficulty (non-adaptive). The goal is to see which game better improves motor skills learning and attention in older adults.See study design
What are the potential side effects?
Since this trial involves playing virtual reality games, potential side effects might include dizziness, nausea, eye strain or headaches due to VR use. However, these are typically mild and temporary.

SAVinGs Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My vision is normal or corrected to normal.
Select...
I am 65 years old or older.

SAVinGs Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (before intervention), day 2 and day 3 (at the end of the intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (before intervention), day 2 and day 3 (at the end of the intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cognition - Inhibition cost of response time in immersive virtual reality
Cognition - Response time in immersive virtual reality
Motor function - Upper limb movement smoothness in immersive virtual reality
+1 more
Secondary outcome measures
Activity transfer - Box and Block Test
Activity transfer - TEMPA_glass
Cognition - Number of false positive in immersive virtual reality
+9 more
Other outcome measures
Effectiveness of participants masking
Feasibility - Number of adverse events
Feasibility - Number of drop-outs
+1 more

SAVinGs Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Self-adaptive serious gameExperimental Treatment1 Intervention
Participants in this arm will follow, during three consecutive days, a serious game (REAsmashVR) intervention whose difficulty is automatically and progressively adapted to their motor and cognitive performance. REAsmashVR involves finding a target as fast as possible. The virtual target (a mole wearing a red miner's helmet) is presented with distractors (moles wearing different helmets). Participants use a controller to hit the target mole with a virtual hammer. In this arm, the REAsmashVR version uses a regulator to continuously moderate the location and timing of appearance of the target mole, the number and type of distractors and the working area. This regulator enables users to score 75% successful performance (driving motivation to play / learn).
Group II: Non-adaptive serious gamePlacebo Group1 Intervention
Participants in this arm will follow, during three consecutive days, a serious game (REAsmashVR) intervention whose difficulty is not automatically adapted to their motor and cognitive performance. In this arm, the REAsmashVR version does not use a regulator to continuously adapt exercise difficulty according to user performance. Instead, the game randomly moderates the location of the target mole, the working area and the type of distractors. The appearance timing remains constant at 7 seconds, while the number of distractors gradually increases over time to simulate an adaptive game environment, ensuring participants are kept unaware of the intervention.

Find a Location

Who is running the clinical trial?

Université Catholique de LouvainOTHER
154 Previous Clinical Trials
47,097 Total Patients Enrolled
1 Trials studying Aging
24 Patients Enrolled for Aging
Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,230 Total Patients Enrolled
2 Trials studying Aging
341 Patients Enrolled for Aging
Charles Sebiyo Batcho, PT, PhDPrincipal InvestigatorLaval University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients currently able to enroll in this ongoing study?

"Indeed, the information available on clinicaltrials.gov confirms that this trial is currently in the recruitment phase. The initial posting of the trial took place on January 9th, 2024 and it was last updated on the same day. The study aims to enroll a total of 42 participants from a single site."

Answered by AI

Which individuals meet the eligibility criteria to be considered for inclusion in this research study?

"To be eligible for this research study, participants must be within the age range of 65 to 95 years old. The trial is currently seeking approximately 42 individuals who meet these criteria."

Answered by AI

What is the overall count of individuals involved in this clinical research?

"Indeed, according to the information provided on clinicaltrials.gov, this ongoing clinical trial is actively seeking individuals for participation. The initial posting of the trial occurred on January 9th, 2024 and there was a recent update made on the same date. This trial aims to recruit a total of 42 participants at one specific location."

Answered by AI

Is there an age limit for participants in this medical study, specifically with regards to individuals above 35 years of age?

"As per the eligibility requirements of this clinical trial, individuals aged 65 to 95 years old are eligible for enrollment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Self-Adaptive Immersive Virtual Reality Serious Game to Enhance Motor Skill Learning and Attention in Older Adults
2024. "Self-Adaptive Immersive Virtual Reality Serious Game to Enhance Motor Skill Learning and Attention in Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06141642.
~26 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top